Animal Experiment of Security Evaluation of TRL Type Hyperthermic Intraperitoneal Treatment System for Coelom Continued Circulatory Hyperthermia Perfusion

GUO Shan,LI Na,WANG Tong-fei,MIN Jie,LIU Li-li,ZHENG Yong,CHEN Dong-xu,ZHANG He-long
DOI: https://doi.org/10.3969/j.issn.1672-4992.2010.03.11
2011-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the impact of Coelom Continued Circulatory Hyperthermia Perfusion(CCCHP) by TRL type hyperthermic intraperitoneal treatment system with different temperature and treatment conditions on experimental animals vital signs and important organs pathology.Further to search optimal temperature and the way to control intraperitoneal perfusion temperature effectually.Methods:Sixteen medical fitness mongrel dogs were experimented with TRL type hyperthermic intraperitoneal treatment system at 41℃(normal saline group and DDP group),42℃(normal saline group) and 43℃(normal saline group) intraperitoneal temperature.CCCHP was performed three times(one hours per time).During CCCHP,The dogs' vital signs and instrument parameters were recorded.The animals hepatic and kidney function changes of CCCHP were inspected before the course and after the last CCCHP by preserved blood specime.The general morphological changes and pathological changes of abdominal organs were inspected after the administration 24 hours and 2 weeks.Results:Single CCCHP 41℃ three times has no obvious effects on vital signs and hepatic,renal functions of experiment animals.The liver,kidney,spleen and intestine have only slightly pathological impairments after CCCHP,and which can quickly recover.CCCHP combined with DDP chemotherapy 41℃ three times has no obvious effects on normal physiologic function.CCCHP at 42℃ and 43℃ three times have significant effects to hepatic and renal functions of experiment animals,and liver,kidney,spleen and intestine has significant pathological impairments in different degree after CCCHP.The impairments aggravated with increasing temperature.Conclusion:41℃ intraperitoneal temperature CCCHP three times(one hours per time) is safe and feasible,so it can be choose as conventional thermochemotherapy temperature with CCCHP.
What problem does this paper attempt to address?